Personalis at Precision: Colorectal Cancer Summit: July 14-15, 2020

Kedar Hastak, PhD
Field Application Scientist

Tuesday, July 14 | 12:00 PM Pacific

Comprehensive solid tumor profiling enables composite biomarker discovery for immunotherapy response

• ImmunoID NeXT combines highly sensitive, exome-scale DNA and RNA sequencing with advanced analytics to provide a broad view of the tumor and the immune-related components of the tumor microenvironment from a single sample preparation
• We will feature a case study demonstrating the ability of this unique, innovative immunogenomics profiling platform to uncover tumor escape mechanisms and to identify composite biomarkers of potentially greater predictive capacity

Connect with us at Precision: Colorectal Cancer Summit 2020